Acetaminophen News and Research

RSS
The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
Use of aspirin and statins can reduce depression: Study

Use of aspirin and statins can reduce depression: Study

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Xanodyne Pharmaceuticals decides to voluntarily remove propoxyphene from the U.S. market

Merck wins third FOSAMAX bellwether trial

Merck wins third FOSAMAX bellwether trial

CMS grants Qutenza J-code to NeurogesX

CMS grants Qutenza J-code to NeurogesX

Labopharm receives notice about Activis' ANDA for OLEPTRO

Labopharm receives notice about Activis' ANDA for OLEPTRO

Labopharm receives notice of Activis' ANDA submission for generic OLEPTRO

Labopharm receives notice of Activis' ANDA submission for generic OLEPTRO

Labopharm third quarter total revenue increases to $9.6 million

Labopharm third quarter total revenue increases to $9.6 million

Childhood asthma risk linked with prenatal paracetamol exposure depends on antioxidant genes in mother

Childhood asthma risk linked with prenatal paracetamol exposure depends on antioxidant genes in mother

FDA grants Cadence marketing approval for OFIRMEV injection in management of pain and fever

FDA grants Cadence marketing approval for OFIRMEV injection in management of pain and fever

NeurogesX initiates NGX-1998 Phase 2 study in postherpetic neuralgia

NeurogesX initiates NGX-1998 Phase 2 study in postherpetic neuralgia

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

NeurogesX plans U.S. label expansion for Qutenza in HIV-associated neuropathy

Elorac acquires world-wide rights to Cidoxepin

Elorac acquires world-wide rights to Cidoxepin

Acetadote Injection is now commercially available in Australia

Acetadote Injection is now commercially available in Australia

Labopharm, Paladin Labs expand commercial relationship

Labopharm, Paladin Labs expand commercial relationship

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Research-based tip sheets provide details on breast cancer

Research-based tip sheets provide details on breast cancer

IV ibuprofen effective in reducing fever in hospitalized patients

IV ibuprofen effective in reducing fever in hospitalized patients

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.